| BMC Biotechnology | |
| An engineered food-grade Lactococcus lactis strain for production and delivery of heat-labile enterotoxin B subunit to mucosal sites | |
| Research Article | |
| Yuanlin Xi1  Qingtang Fan1  Chen Wang1  Shuaiyin Chen1  Xiaoyan Peng1  Guangcai Duan2  Rongguang Zhang2  Nan Sun2  | |
| [1] Department of Epidemiology and Statistics, College of Public Health, Zhengzhou University, 450001, Zhengzhou, China;Department of Epidemiology and Statistics, College of Public Health, Zhengzhou University, 450001, Zhengzhou, China;Henan Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, 453003, Xinxiang, China; | |
| 关键词: Helicobactor pylori; Lactococcus lactis; Lpp20; Food-grade; Oral vaccine; LTB; | |
| DOI : 10.1186/s12896-017-0345-6 | |
| received in 2016-08-18, accepted in 2017-03-01, 发布年份 2017 | |
| 来源: Springer | |
PDF
|
|
【 摘 要 】
BackgroundRecent researches have been focusing on mucosal immune adjuvants, which play the key roles in mucosal immunization and have become the limitation for non-injected vaccine development. Escherichia coli heat-labile enterotoxin B subunit (LTB) was regarded as a promising mucosal adjuvant for its nontoxicity and potent activity. LTB preparation issues have always been recurring, in part owing to that the recombinant LTB expressed by E. coli does not act as its native form.ResultsWe constructed an engineered Lactococcus lactis strain using a food-grade expression system. The LTB secreted by the engineered strain was detected in the culture supernatant, constituting 10.3% of the supernatant proteins, and recognized by mouse anti-LTB antibodies. The engineered strain, co-administered orally to SPF BALB/c mice with a H. pylori vaccine candidate expressing Lpp20 antigen, could significantly enhance the Lpp20-induced mucosal SIgA antibody responses against H. pylori.ConclusionsThis is the first report that LTB was efficiently produced and delivered via using a food-grade lactococcal expression system, which offers a novel production and utilization mode of this crucial mucosal adjuvant. The engineered L. lactis strain secreting LTB has considerable potential for oral vaccine formulation owing to its outstanding safety, adjuvant activity and high-level production.
【 授权许可】
CC BY
© The Author(s). 2017
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202311095225458ZK.pdf | 2175KB | ||
| 12896_2017_345_Article_IEq1.gif | 1KB | Image |
【 图 表 】
12896_2017_345_Article_IEq1.gif
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
PDF